Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
19-22 October, 2025
Not Confirmed
Not Confirmed
20-22 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
11 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/11/3148395/0/en/RadioMedix-and-Vect-Horus-Announce-First-Patient-Dosed-in-Exploratory-Clinical-Study-of-203Pb-RMX-VH-PIB-for-Glioblastoma-Multiforme-and-Pancreatic-Ductal-Adenocarcinoma.html
12 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/12/3098408/0/en/RadioMedix-Debuts-Proprietary-bench-top-Pb-Generator-to-Support-Targeted-Alpha-Therapy-Development.html
12 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/12/2944919/0/en/Press-Release-Sanofi-RadioMedix-and-Orano-Med-announce-licensing-agreement-on-next-generation-radioligand-medicine-for-rare-cancers.html
12 Feb 2024
// BUSINESSWIRE
15 Feb 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/02/15/2608809/0/en/RadioMedix-Inc-Announces-the-Acquisition-of-its-225Ac-PSMA-I-T-program-a-Targeted-Alpha-Therapy-TAT-for-Metastatic-Castration-Resistant-Prostate-Cancer-by-Fusion-Pharmaceuticals-In.html
15 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/11/15/2555865/0/en/RadioMedix-and-Vect-Horus-announce-first-dosing-of-Glioblastoma-Multiforme-and-Pancreatic-ductal-adenocarcinoma-patients-with-68Ga-RMX-VH.html
ABOUT THIS PAGE